Panel Discussion: Key Considerations to Future Proof Analytical Development Efforts

11:30 am - Tuesday 2nd December 2025

  •  How can we ensure sufficient sample retention early to support unforeseen testing and regulatory requirements
  • Manage the underestimated complexity and time demands of cell-based and potency assay development
  • What are some opportunities for platforming assays to reduce duplication and streamline multi-program assay workflows?

Speakers:

Principal Scientist - CMC & Analytical Development group
Aurion Biotech
Principal Engineer - Quality
Avobis Bio, LLC